Pharmacotherapies for cannabis use disorder.
Spiga F, Parkhouse T, Tang VM, Savović J, Le Foll B, Nielsen S.
Spiga F, et al.
Cochrane Database Syst Rev. 2025 Sep 30;9(9):CD008940. doi: 10.1002/14651858.CD008940.pub4.
Cochrane Database Syst Rev. 2025.
PMID: 41025421
Five studies targeted participants with comorbidities (depression (2), bipolar disorder (1), and attention deficit hyperactivity disorder (1)). ...SAE may be no more likely with THC preparations (RR 0.99, 95% CI 0.25 to 3.9; 7 studies, 584 participants …
Five studies targeted participants with comorbidities (depression (2), bipolar disorder (1), and attention deficit hype …